Company Filing History:
4 out of 925 
1 out of 152 
Years Active: 2023-2025
Title: Jun Ishihara: Innovator in Cancer Treatment and Wound Healing
Introduction
Jun Ishihara is a notable inventor based in Chicago, IL (US), recognized for his contributions to medical therapies. He holds 4 patents that focus on innovative methods for treating cancer and enhancing wound healing. His work is characterized by a commitment to improving patient outcomes through targeted therapies.
Latest Patents
Ishihara's latest patents include groundbreaking methods and compositions for treating cancer with ECM-affinity peptides linked to cytokines. These methods provide a therapy that specifically targets and retains cytokines within tumor environments, thereby limiting systemic exposure and reducing side effects. Additionally, he has developed methods and compositions for the treatment of wounds, utilizing peptides and polypeptides that comprise a growth factor binding domain. These peptides are designed to promote healing and are characterized by specific amino acid sequences.
Career Highlights
Throughout his career, Jun Ishihara has worked with prestigious institutions, including the University of Chicago. His research has significantly advanced the field of immunotherapy and regenerative medicine, showcasing his dedication to innovation in healthcare.
Collaborations
Ishihara has collaborated with notable colleagues, including Ako Ishihara and Jeffrey Alan Hubbell. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic approaches.
Conclusion
Jun Ishihara's innovative work in cancer treatment and wound healing exemplifies the impact of targeted therapies in modern medicine. His contributions continue to pave the way for advancements in patient care and treatment efficacy.